[
  {
    "ts": null,
    "headline": "New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer",
    "summary": "Largest ever meta-analysis on the long-term benefits of CPAP therapy, published in The Lancet Respiratory Medicine, found that in people with sleep apnea, CPAP therapy lowered the overall chance of dying by 37% and the chance of heart-related death by 55%.SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the publication of a landmark meta-analysis in The L",
    "url": "https://finnhub.io/api/news?id=6da5dc39cbd8d1dab7ffcbff2448040863d32289080b60b255fe4dabfa4304d1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742385600,
      "headline": "New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer",
      "id": 133326557,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Largest ever meta-analysis on the long-term benefits of CPAP therapy, published in The Lancet Respiratory Medicine, found that in people with sleep apnea, CPAP therapy lowered the overall chance of dying by 37% and the chance of heart-related death by 55%.SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the publication of a landmark meta-analysis in The L",
      "url": "https://finnhub.io/api/news?id=6da5dc39cbd8d1dab7ffcbff2448040863d32289080b60b255fe4dabfa4304d1"
    }
  }
]